The conversation around treating obstructive sleep apnea has been CPAP-dominated for decades, which makes sense given its effectiveness. But CPAP adherence is famously poor—somewhere around 40-60% of patients stop using it within the first year. Oral appliances present an interesting alternative with very different trade-offs.

Mandibular advancement devices work by holding the lower jaw forward during sleep, which increases the space behind the tongue and reduces airway collapse. They’re custom-fitted by dentists or sleep specialists and look somewhat like mouthguards or orthodontic retainers.

The efficacy data shows oral appliances reduce apnea-hypopnea index by roughly 40-50% on average, compared to CPAP’s 80-95% reduction. That’s a meaningful difference. For someone with an AHI of 30, CPAP might bring them down to 2-3 events per hour, while an oral appliance might get them to 15-18. Still significant apnea, though substantially improved from baseline.

Where oral appliances shine is adherence. Long-term compliance studies consistently show 70-80% of patients still using their devices at one year, compared to the much lower CPAP numbers. People find them more tolerable—no mask, no machine noise, no hose, easier for travel, and less claustrophobic.

This creates a clinical dilemma: do you recommend the more effective treatment that patients probably won’t use consistently, or the less effective treatment they’re more likely to stick with? For mild sleep apnea, oral appliances are increasingly becoming first-line therapy because the adherence advantage outweighs the efficacy gap.

For moderate sleep apnea, the calculus is murkier. Guidelines generally still favor CPAP, but individual patient factors matter enormously. Someone with claustrophobia, frequent business travel, or who’s failed previous CPAP attempts might get more actual therapeutic benefit from a less-effective device they’ll actually use nightly.

Severe sleep apnea remains firmly CPAP territory. The cardiovascular and metabolic risks are too high to accept partial treatment. That said, some patients with severe apnea who categorically refuse CPAP still benefit from oral appliances as a harm-reduction approach—imperfect treatment is better than none.

Predicting who’ll respond well to oral appliances remains imprecise. Drug-induced sleep endoscopy can visualize airway collapse patterns and supposedly predicts appliance effectiveness, but the correlation is modest. Some patients with favorable anatomy get minimal benefit, while others respond better than predicted.

The fitting process matters considerably. Over-the-counter boil-and-bite devices don’t work nearly as well as custom-fabricated appliances with proper titration. The amount of jaw advancement needs to be optimized—too little gives inadequate apnea reduction, too much causes temporomandibular joint problems and tooth discomfort.

Side effects are real but generally mild. Jaw soreness, excess salivation, dry mouth, and tooth discomfort are common initially and usually resolve within weeks. Longer-term concerns include bite changes and TMJ issues, particularly if the device isn’t properly adjusted or if patients clench their jaw against it during sleep.

Follow-up sleep studies after oral appliance fitting are recommended but don’t always happen. Without objective verification of treatment efficacy, there’s no way to know if the appliance is actually controlling the apnea adequately. Some patients feel subjectively better from the placebo effect or improved sleep position without meaningful AHI reduction.

The cost of oral appliances varies widely. Basic custom devices might cost $1500-2000, while advanced designs with precise adjustment mechanisms run $3000-4000. Insurance coverage is inconsistent—some plans cover them for diagnosed sleep apnea, others don’t or require failed CPAP trial first.

Dental expertise in sleep medicine varies enormously. Some dentists have extensive training in sleep appliances and work closely with sleep physicians. Others have minimal experience and fit devices without adequate assessment or follow-up. Finding a qualified provider makes a substantial difference in outcomes.

Combination therapy is underutilized. Some patients do well with an oral appliance plus positional therapy to avoid supine sleeping, or appliance plus weight loss, or appliance for travel with CPAP at home. These hybrid approaches can optimize both efficacy and adherence.

Weight loss effects on oral appliance efficacy are interesting. Significant weight reduction can improve appliance effectiveness by reducing overall tissue bulk in the airway. Conversely, weight gain after fitting might reduce effectiveness below therapeutic levels.

There’s patient selection bias in appliance studies worth acknowledging. People willing to participate in oral appliance research are probably not representative of the general sleep apnea population—they’re likely more motivated, health-conscious, and adherent than average. Real-world outcomes might be somewhat worse than published data suggests.

The discussion around treatment goals needs nuance. Complete normalization of AHI isn’t always achievable or necessary. Reducing someone’s AHI from 35 to 12 while improving their sleep quality, daytime function, and long-term health risks represents successful treatment even if it’s not perfect.

Patient preference legitimately factors into treatment selection. Sleep apnea therapy is long-term or lifelong. If a patient has strong preferences based on their lifestyle, comfort, or previous experiences, those should inform the decision alongside efficacy data. Shared decision-making produces better outcomes than prescriptive approaches.

The evidence base for oral appliances has improved considerably over the past decade. Multiple randomized trials now show cardiovascular benefits comparable to CPAP in patients who actually use their prescribed therapy—adherence-adjusted outcomes rather than just efficacy under ideal conditions.

Innovation in appliance design continues. Newer devices offer finer adjustment, better retention, reduced bulk, and improved comfort. Some incorporate sensors to track actual usage time, providing objective adherence data similar to CPAP download reports.

For the right patient population—primarily mild-to-moderate sleep apnea without severe obesity or craniofacial abnormalities—oral appliances represent effective first-line therapy with adherence rates that often translate to better real-world outcomes than theoretically superior but poorly tolerated CPAP.

The key is proper patient selection, adequate fitting and titration, objective verification of treatment efficacy, and regular follow-up. When those elements align, oral appliances are a valuable tool in sleep apnea management that deserves more than being relegated to “CPAP alternative” status.